Abstract
The limitations of current antimicrobials for highly virulent pathogens considered as potential bioterrorism agents drives the requirement for new antimicrobials that are suitable for use in populations in the event of a deliberate release. Strategies targeting bacterial virulence offer the potential for new countermeasures to combat bacterial bioterrorism agents, including those active against a broad spectrum of pathogens. Although early in the development of antivirulence approaches, inhibitors of bacterial type III secretion systems and cell division mechanisms show promise for the future. © 2011 Future Medicine Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | 667-676 |
| Number of pages | 10 |
| Journal | Future Microbiology |
| Volume | 6 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2011 |